Similarly, miR-19a, miR-21 and miR-27a were remarkably down-regulated in BC patients with inhibited TIMP3 protein expression (P=0.019, 0.021 and 0.01) with fold changes being 0.151, 0.292 and 0.075, respectively. The gene discussed is TIMP3; the disease is breast cancer.